SEARCH

SEARCH BY CITATION

References

  • 1
    Mitchison T.J. (1994) Towards a pharmacological genetics. Chem Biol;1:36.
  • 2
    King R.K. (1999) Chemistry or biology: which comes first after the genome is sequenced? Chem Biol;6:R327R333.
  • 3
    Schrieber S.L. (1998) Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg Med Chem; 6:11271152.
  • 4
    Mayer T.U., Kapoor T.M., Haggarty S.J., King R.W., Schreiber S.L., Mitchison T.J. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science;286:971974.
  • 5
    Zon L.I., Peterson R.T. (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov;4:3544.
  • 6
    Stern H.M., Zon L.I. (2003) Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer;3:533539.
  • 7
    Peterson R.T., Link B.A., Dowling J.E., Schreiber S.L. (2000) Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA;97:1296512969.
  • 8
    Khersonsky S.M., Jung D.W., Kang T.W., Walsh D.P., Moon H.S., Jo H., Jacobson E.M., Shetty V., Neubert T.A., Chang Y.T. (2003) Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc;125:1180411805.
  • 9
    Langheinrich U., Hennen E., Stott G., Vacun G. (2002) Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol;12:20232028.
  • 10
    Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., Plasterk R., Zon L.I., Look A.T. (2005) tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA;102:407412.
  • 11
    Imamura S., Kishi S. (2005) Molecular cloning and functional characterization of zebrafish ATM. Int J Biochem Cell Biol;37:11051116.
  • 12
    Ikegami R., Zhang J., Rivera-Bennetts A.K., Yager T.D. (1997) Activation of the metaphase checkpoint and an apoptosis programme in the early zebrafish embryo, by treatment with the spindle-destabilising agent nocodazole. Zygote;5:329350.
  • 13
    Ikegami R., Hunter P., Yager T.D. (1999) Developmental activation of the capability to undergo checkpoint induced apoptosis in the early zebrafish embryo. Dev Biol;209:409433.
  • 14
    Haggarty S.J., Mayer T.U., Miyamoto D.T., Fathi R., King R.W., Mitchison T.J., Schreiber S.L. (2000) Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem Biol;7:275286.
  • 15
    Stern H.M., Murphey R.D., Shepard J.L., Amatruda J.F., Straub C.T., Pfaff K.L., Weber G., Tallarico J.A., King R.W., Zon L.I. (2005) Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol;1:366370.
  • 16
    Hendzel M.J., Wei Y., Mancini M.A., Van Hooser A., Ranalli T., Brinkley B.R., Bazett-Jones D.P., Allis C.D. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma;106:348360.
  • 17
    Milan D.J., Peterson T.A., Ruskin J.N., Peterson R.T., MacRae C.A. (2003) Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation;107:13551358.